» Articles » PMID: 14601060

A Cross-sectional Investigation of Breast Density and Insulin-like Growth Factor I

Overview
Journal Int J Cancer
Specialty Oncology
Date 2003 Nov 6
PMID 14601060
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Our study investigated the association of breast cancer risk as assessed by mammographic density with insulin-like growth factor I (IGF-I) and one of its binding proteins (IGFBP-3) in healthy premenopausal women with different ethnic backgrounds. In a cross-sectional design, we analyzed the baseline mammograms and fasting serum samples (collected 5 days after ovulation) of premenopausal women entering a nutritional intervention. Serum concentrations of IGF-I and IGFBP-3 were measured by double-antibody ELISA. Mammographic densities were assessed using a computer-assisted method. We calculated Spearman correlation coefficients between mammographic characteristics and analytes and estimated means of mammographic characteristics by quartiles of IGF-I and IGFBP-3 while adjusting for age, body mass index (BMI) and reproductive factors. In this group of 240 women, IGF-I, IGFBP-3 and percent densities did not differ significantly by ethnicity. Whereas mammographic densities were not associated with IGF-I, we found an inverse relation with IGFBP-3 (r(s) = -0.15, p = 0.02) and a positive association with the IGF-I/IGFBP-3 ratio (r(s) = 0.13, p = 0.04). The size of the dense areas was not associated with the analytes, but the size of the nondense areas was correlated directly with IGFBP-3 (r(s) = 0.20, p = 0.002) and inversely with the molar ratio (r(s) = -0.19, p = 0.004). These associations were limited to women with a BMI of less than 25 kg/m(2). These results suggest that the balance of circulating IGF-I and IGFBP-3 levels may influence the growth of the fatty part of the breast more than the epithelial and stromal breast tissue, but the exact mechanism of action needs to be explored in more detail.

Citing Articles

Lipidome of mammographic breast density in premenopausal women.

Getz K, Jeon M, Luo C, Luo J, Toriola A Breast Cancer Res. 2023; 25(1):121.

PMID: 37814330 PMC: 10561435. DOI: 10.1186/s13058-023-01725-1.


Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.

Oh H, Pfeiffer R, Falk R, Horne H, Xiang J, Pollak M Int J Cancer. 2018; 143(3):496-507.

PMID: 29473153 PMC: 6019124. DOI: 10.1002/ijc.31333.


Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.

Rinaldi S, Biessy C, Hernandez M, Lesueur F, dos-Santos-Silva I, Rice M Int J Cancer. 2013; 134(6):1436-44.

PMID: 24037648 PMC: 4487637. DOI: 10.1002/ijc.28469.


Correlation between insulin resistance and breast elasticity heterogeneity measured by shear wave elastography in premenopausal women - a pilot study.

Rzymski P, Wysocki P, Kycler W, Opala T Arch Med Sci. 2012; 7(6):1017-22.

PMID: 22328885 PMC: 3264994. DOI: 10.5114/aoms.2011.26614.


The vitamin D pathway and mammographic breast density among postmenopausal women.

Sprague B, Trentham-Dietz A, Gangnon R, Buist D, Burnside E, Aiello Bowles E Breast Cancer Res Treat. 2011; 131(1):255-65.

PMID: 21847642 PMC: 3250989. DOI: 10.1007/s10549-011-1726-5.